Attached files
file | filename |
---|---|
8-K - FORM 8-K - Inspyr Therapeutics, Inc. | v330187_8k.htm |
EXHIBIT 16.1
RBSM LLP
New York, NY
December 12, 2012
Securities and Exchange Commission
100 F Street, N.W.
Washington, DC 20549-7561
Dear Sirs/Madams:
We have read Item 4.01 of Genspera, Inc. (the “Company”) Form 8-K dated December 12, 2012, and are in agreement with the statements relating only to RBSM LLP contained therein. We have no basis to agree or disagree with other statements of the Company contained therein
Very truly yours,
S/S RBSM LLP